Publications in 2010

Hallett M, 2010

Rose AA, Annis MG, Dong Z, Pepin F, Hallett M, Park M, Siegel PM (2010) ADAM10 releases a soluble form of the GPNMB/Osteoactivin extracellular domain with angiogenic properties. PLoS One 5(8):e12093. PMID: 20711474.

Ursini-Siegel J, Cory S, Zuo D, Hardy W, Rexhepaj E, LamS, Schade B, Jirstrom K, Bjur E, Piccirillo C, DeNardo D, Coussens L,Brennan D, Gallagher W, Park M, Pawson T, Hallett M, Muller W (2010) Receptor Tyrosine Kinase Signaling in Breast Cancer Cells Inhibits the Adaptive Immune Response to Favor a Pro-Tumorigenic State. Cancer Research 70(20):7776-87. PMID: 20924104.

Perkins T, Hallett M. (2010) A trade-off between sample complexity and computational complexity in learning Boolean networks from time series data. Transactions on Computational Biology and Bioinformatics 7(1):118-25. PMID: 20150674

Muggerud AA, Hallett M, Johnsen H, Kleivi K, Zhou W, Tahmasebpoor S, Amini RM, Botling J, Børresen-Dale AL, Sørlie T, Wärnberg F (2010) Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer. Molecular Oncology 4(4):357-68. PMID: 20663721.

Lee AY, Perreault R, Harel S, Boulier E, Suderman M, Hallett M, Jenna S (2010) Searching for Signaling Balance through the Identification of Genetic Interactors of the Rab Guanine-Nucleotide Dissociation Inhibitor gdi-1 PLoS ONE 5(5):e10624. PMID: 20498707.

Epp E, Vanier G, Harcus D, Lee AY, Jansen G, Hallett M, Sheppard D, Thomas D, Munro CA, Mullick A, Whiteway M (2010) Reverse Genetics in Candida albicans Predicts ARF Cycling is Essential for Drug Resistance and Virulence. PLoS Pathogens 6(2):e1000753. PMID: 20140196.

Rose AA, Grosset A-A, Dong Z, Russo C, MacDonald P, Bertos N, St-Pierre Y, Simantov R, Hallett M, Park M, Gaboury L, Siegel P (2010) GPNMB is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer. Cancer Research 16(7):2147-56. PMID: 20215530.